International Clinical Trial: Research on Malignant Risk Prediction of BI-RADS Category 4 Breast Nodules Based on Multi-Omics Data

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132075) titled 'Research on Malignant Risk Prediction of BI-RADS Category 4 Breast Nodules Based on Multi-Omics Data' on Sept. 9.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Affiliated Hospital of Chengdu University of Traditional Chinese Medicine

Condition: BI-RADS Category 4 breast nodules

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2023-09-18

Target Sample Size: The observation group of BI-RADS category 4 breast nodules:715;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=288333

Published by HT Digital Conte...